Inceptor Bio
2405 Perimeter Park Dr Suite 200 Morrisville, North Carolina 27560, UShttps://www.inceptor.bio/Therapeutics
Inceptor Bio is a clinical-stage biotechnology company focused on developing next-generation cell therapies. The company is dedicated to addressing unmet medical needs, exemplified by its lead program, IB-T101, which targets clear cell Renal Cell Carcinoma (ccRCC).
Leadership & Board
- Current Number of Employees
- 20
- Current LinkedIn Followers
- 5,263
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $21M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $21M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
Inceptor Bio had 20 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Inceptor Bio had 5,263 followers as of October 12, 2026. The number of followers decreased by 1 (0.02%) week-over-week.
5,263Latest Followers Count
1(-0.02%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 25, 2025 | Series A | $21.00M | ― |
Similar Companies
A snapshot of private companies similar to Inceptor Bio, helping you discover and navigate related company profiles.
Related News and Analysis
